tetano
Editor, Senior Moderator
J Infect Dis
. 2022 Sep 16;jiac379.
doi: 10.1093/infdis/jiac379. Online ahead of print.
Regimen of COVID-19 vaccination influences extent and kinetics of antibody avidity
Annika Rössler[SUP] 1 [/SUP], Janine Kimpel[SUP] 1 [/SUP], Verena Fleischer[SUP] 2 [/SUP], Silke Huber[SUP] 2 [/SUP], Dorothee von Laer[SUP] 1 [/SUP], Wegene Borena[SUP] 1 [/SUP], Reinhard Würzner[SUP] 2 [/SUP]
Affiliations
Abstract
We investigated antibody titers and avidity after heterologous versus homologous coronavirus disease 2019 (COVID-19) vaccination over six months following the second dose. We found a significantly higher avidity in regimens including at least one dose of the adenoviral vector vaccine ChAdOx1-S compared to two doses of the mRNA vaccine BNT162b2.
Keywords: SARS-CoV-2; antibody kinetics; avidity; heterologous vaccination.
. 2022 Sep 16;jiac379.
doi: 10.1093/infdis/jiac379. Online ahead of print.
Regimen of COVID-19 vaccination influences extent and kinetics of antibody avidity
Annika Rössler[SUP] 1 [/SUP], Janine Kimpel[SUP] 1 [/SUP], Verena Fleischer[SUP] 2 [/SUP], Silke Huber[SUP] 2 [/SUP], Dorothee von Laer[SUP] 1 [/SUP], Wegene Borena[SUP] 1 [/SUP], Reinhard Würzner[SUP] 2 [/SUP]
Affiliations
- PMID: 36111560
- DOI: 10.1093/infdis/jiac379
Abstract
We investigated antibody titers and avidity after heterologous versus homologous coronavirus disease 2019 (COVID-19) vaccination over six months following the second dose. We found a significantly higher avidity in regimens including at least one dose of the adenoviral vector vaccine ChAdOx1-S compared to two doses of the mRNA vaccine BNT162b2.
Keywords: SARS-CoV-2; antibody kinetics; avidity; heterologous vaccination.